ABBV AbbVie PE ratio, current and historical analysis
As at Apr 1, 2025, the ABBV stock has a PE ratio of 85.95. This is based on the current EPS of $2.4 and the stock price of $206.27 per share. An increase of 35% has been seen in the P/E ratio compared to the average of 63.5 of the last 4 quarters.
ABBV PE ratio history
The mean historical PE ratio of AbbVie over the last ten years is 29.67. The current 85.95 PE ratio is 190% above the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Dec 2024 quarter at 74.04, with a price of $177.7 and an EPS of $2.4. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.
AbbVie PE ratio by year
Maximum annual increase: 187.98% in 2014
Maximum annual decrease: -68.09% in 2015
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 74.04 | 30.42% | $177.7 | $2.4 |
| 2023 | 56.77 | 133.62% | $154.97 | $2.73 |
| 2022 | 24.3 | 16.27% | $161.61 | $6.65 |
| 2021 | 20.9 | -46.75% | $135.4 | $6.48 |
| 2020 | 39.25 | 134.89% | $107.15 | $2.73 |
| 2019 | 16.71 | -33.48% | $88.54 | $5.3 |
| 2018 | 25.12 | -14.03% | $92.19 | $3.67 |
| 2017 | 29.22 | 70.28% | $96.71 | $3.31 |
| 2016 | 17.16 | -8.77% | $62.62 | $3.65 |
| 2015 | 18.81 | -68.09% | $59.24 | $3.15 |
| 2014 | 58.95 | 187.98% | $65.44 | $1.11 |
| 2013 | 20.47 | N/A | $52.81 | $2.58 |
| 2012 | N/A | N/A | N/A | $3.35 |
| 2011 | N/A | N/A | N/A | $2.18 |
| 2010 | N/A | N/A | N/A | $2.65 |
AbbVie PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 74.04 | 7.98% | $177.7 | $2.4 |
| Sep 2024 | 68.57 | 19.94% | $197.48 | $2.88 |
| Jun 2024 | 57.17 | 5.79% | $171.52 | $3 |
| Mar 2024 | 54.04 | -4.81% | $182.1 | $3.37 |
| Dec 2023 | 56.77 | 39.38% | $154.97 | $2.73 |
| Sep 2023 | 40.73 | 47.52% | $149.06 | $3.66 |
| Jun 2023 | 27.61 | -26.2% | $134.73 | $4.88 |
| Mar 2023 | 37.41 | 53.95% | $159.37 | $4.26 |
| Dec 2022 | 24.3 | 36.36% | $161.61 | $6.65 |
| Sep 2022 | 17.82 | -17.5% | $134.21 | $7.53 |
| Jun 2022 | 21.6 | -6.86% | $153.16 | $7.09 |
| Mar 2022 | 23.19 | 10.96% | $162.11 | $6.99 |
| Dec 2021 | 20.9 | -19.58% | $135.4 | $6.48 |
| Sep 2021 | 25.99 | -15.31% | $107.87 | $4.15 |
| Jun 2021 | 30.69 | -20.88% | $112.64 | $3.67 |
ABBV average PE ratio chart
ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.
ABBV PE vs peers
ABBV's PE ratio is lower than its peer stock GILD, but it is greater than LLY's and AZN's. AbbVie's current PE ratio of 85.95 is above the average of its peers, which is 33.54.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 11.78 | $19.33B |
| PFE Pfizer Inc | 17.28 | $139.08B |
| NBIX Neurocrine Biosciences Inc | 31.47 | $10.67B |
| AZN Astrazeneca plc | 31.98 | $225.14B |
| AMGN Amgen Inc | 40.28 | $164.88B |
| LLY ELI LILLY & Co | 68.47 | $763.49B |
| ABBV AbbVie Inc | 85.95 | $364.14B |
| GILD Gilead Sciences Inc | 292.84 | $138.58B |
| BMY Bristol Myers Squibb Co | N/A | $120.85B |
Frequently asked questions
What is AbbVie's PE ratio?
As of Apr 1, 2025, ABBV stock has a price to earnings ratio of 85.95.
What is the 3-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 3 years is 43.64.
What is the 5-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 5 years is 36.74.
What is the highest PE ratio for ABBV?
Within the last ten years, the current P/E ratio is at its peak with a value of 85.95.
How does the current PE ratio for ABBV compare to its historical average?
ABBV's current price to earnings ratio is 190% above its 10-year historical average.
Why is AbbVie's PE ratio so high?
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 1, 2025), AbbVie's stock price is $206.27. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.4. Therefore, AbbVie's P/E ratio for today is 85.95. PE RATIO(85.95) = STOCK PRICE($206.27) / TTM EPS($2.4)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.